Neoplastic Heterogeneity and Clinical Chemotherapy

  • Stephen K. Carter
Part of the Cancer Growth and Progression book series (CAGP, volume 1)


Cancer chemotherapy is a modality in transition. In its early days, chemotherapy was viewed with skepticism by many, and its pioneers were forced to emphasize its positives in an aggressively defensive manner. In the early 1970s, chemotherapy appeared poised to possibly become a dominant modality. This was caused by the concept of adjuvant chemotherapy which appeared validated by the early relapse-free survival gains reported in the treatment of primary breast cancer. A decade later it is obvious that adjuvant chemotherapy is not a dramatic breakthrough and that the modality itself has plateaued in its ability to cure and palliate malignant disease.


Adjuvant Chemotherapy Primary Disease Limb Salvage Biologic Heterogeneity Clinical Chemotherapy 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Carter SK, Bakowski M, Hellmann K: Chemotherapy of Cancer, 2nd edition. John Wiley and Sons, NY, 1981Google Scholar
  2. 2.
    Carter SK, Livingston RG, Glatstein E: Principles of Cancer Treatment. McGraw-Hill, NY, 1982Google Scholar
  3. 3.
    De Vita VT, Hellman S, Rosenberg SA: Cancer Principles and Practice of Oncology, 2nd edition. J.B. Lippincott Co., Philadelphia, 1985Google Scholar
  4. 4.
    Carter SK: Some Thoughts on Resistance to Cancer Chemotherapy Cancer Treatment Reviews 11:3–7, 1984PubMedCrossRefGoogle Scholar
  5. 5.
    Skipper HE, Simpson-Herren L: Relationship between Tumor Stem Cell Heterogeneity and Resistance to Chemotherapy. In: De Vita VT, Hellman S, Rosenberg SA: Important Advances in Oncology, 1985. J.B. Lippincott, Philadelphia, pp. 63–78 1985Google Scholar
  6. 6.
    Chabner BA, Fine RL, Allegra CJ et al: Cancer Chemotherapy Progress and Expectations, 1984. Cancer 54:2599–2608, 1984PubMedCrossRefGoogle Scholar
  7. 7.
    Fidler IJ: Recent Concepts of Cancer Metastasis and Their Implications for Therapy. Cancer Treat Rep 68:193–198, 1984PubMedGoogle Scholar
  8. 8.
    McGuire WL (Moderator), Goldie JH, Salmon SE, Ling V: Strategies to Identify or Prevent Drug Resistance in Cancer — A Panel Discussion. Breast Cancer Res and Treatment 5:257–268, 1985CrossRefGoogle Scholar

Copyright information

© Kluwer Academic Publishers, Dordrecht 1989

Authors and Affiliations

  • Stephen K. Carter

There are no affiliations available

Personalised recommendations